To include your compound in the COVID-19 Resource Center, submit it here.

Losartan: Phase III discontinued

Researchers at the VA and colleagues said the double-blind, U.S. Phase III VA NEPHRON-D trial in 1,448 Type II diabetics with overt nephropathy was stopped

Read the full 250 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE